There is a threat of a lack of the drug Actilyse, which is used for the acute therapy of a cerebral infarction. The only business in the globe that marketplaces the drug is struggling with provide difficulties. “Hospitals are inspired to deal with their stocks responsibly,” says Robin Lemmens, neurologist at UZ Gasthuisberg in Leuven and vice president of the Belgian Stroke Council.
–
Related posts:
The National Vaccination Campaign shows disappointing numbers, but good results are still expected
Nunzio disappointed by Rossella, Marina in severe crisis
NASA and ESA's Most Amazing Close-Up Portraits of the Sun
Ministry of Health Achieves Milestone: 90% of Children in Ecuador Vaccinated Against Polio, Measles,...
